Stay updated on AKB-9778 Tie-2 Activator Clinical Trial

Sign up to get notified when there's something new on the AKB-9778 Tie-2 Activator Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AKB-9778 Tie-2 Activator Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T03:22:57.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A notice about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov error page.
    Difference
    1%
    Check dated 2026-10-25T03:57:32.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2 on the page displaying a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T03:20:51.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T05:26:30.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A 403 Forbidden message appears in the page content, with a Home link, instead of the study record.
    Difference
    0.5%
    Check dated 2026-10-04T08:14:05.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error screen with the standard header/navigation and a Home button. This indicates restricted access to the study record rather than a substantive update to the study content.
    Difference
    0.5%
    Check dated 2026-09-27T06:56:41.000Z thumbnail image

Stay in the know with updates to AKB-9778 Tie-2 Activator Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AKB-9778 Tie-2 Activator Clinical Trial page.